Table 1-.
Gold Standard |
Fluorescent Spot Test |
CareStart™ RDT |
CareStart™ G6PD Biosensor |
STANDARD™ G6PD by SD Biosensor |
“Sample -to- readout” |
BS-240 | |
---|---|---|---|---|---|---|---|
Method | Spectrophotometry | UV fluorescence visualization | Colorization chamber | Biosensor, test strip | Biosensor, test strip | Colorization, fabricated biosensor | Automated UV enzyme system |
Volume | 10μL | 5μL | 2μL | 5μL | 10μL | 15μL | 20μL |
Blood | Venous | Venous | Whole | Whole | Venous or capillary | Whole | Hemolys ate venous blood |
Time | 5-10 min | 10 min + air dry time | 10 min | 4 min | 2 min | 10 min + air dry time | 2 min |
Temperature | 30°C | Room temperature | Variable | Room temperature | Variable | Room temperature | 37°C |
Intermediate Reading* | Yes | No | No | Yes | Yes | Yes | No |
Measurement | Quantitative | Qualitative | Qualitative | Quantitative | Quantitative | Qualitative | Quantitative |
Sensitivity # | Very High | Med-High | Med-High | High | High | Med-High | Med-High |
Specificity # | Very High | Med-High | Med-High | High | High | Med-High | Med-High |
Diagnostic Accuracy# | Very High | Low-Med | Medium | High | Very High | Med-High | Low-Med |
Intermediate readout for the G6PD activity is important for diagnosis on mild/intermediate G6PD deficiency. This provides the scope for determining threshold of G6PD deficiency for safety of therapeutics in G6PD deficient populations.
The performance of individual methods of diagnosis of G6PD deficiency regarding sensitivity, specificity, and diagnostic accuracy is subjective and may not be compared quantitatively.